PMCB 8-K 2026-10-16

PharmaCyte Biotech, Inc. (PMCB) 8-K dated 2026-10-16 — accession 0001683168-26-007934. This URL is the filing, not the PMCB hub.

PharmaCyte Biotech, Inc. (PMCB) is a biotechnology company listed on NASDAQ.

PharmaCyte Biotech, Inc. filed a 8-K on 2026-10-16. Accession 0001683168-26-007934.

Cached items: 4.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported PMCB revenue for 2026-04-30 was $0. Net income was -$19.4M. PMCB currently screens at market cap $8.6M.

Not investment advice. The PMCB SEC hub lists recent forms. The stock page is the research view.